•First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel•We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel.
No takes yet. Share an insight, caveat, or question.
Leon et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: